AI Article Synopsis
Article Abstract
The P2X receptor plays a significant role in microglial activation, and as a potential drug target, the P2X receptor is also an interesting target in positron emission tomography. The current study aimed at the development and evaluation of a potent tracer targeting the P2X receptor, to which end four adamantanyl benzamide analogues with high affinity for the human P2X receptor were labelled with carbon-11. All four analogues could be obtained in excellent radiochemical yield and high radiochemical purity and molar activity, and all analogues entered the rat brain. [C]SMW139 showed the highest metabolic stability in rat plasma, and showed high binding to the hP2X receptor in vivo in a hP2X receptor overexpressing rat model. Although no significant difference in binding of [C]SMW139 was observed between post mortem brain tissue of Alzheimer's disease patients and that of healthy controls in in vitro autoradiography experiments, [C]SMW139 could be a promising tracer for P2X receptor imaging using positron emission tomography, due to high receptor binding in vivo in the hP2X receptor overexpressing rat model. However, further investigation of both P2X receptor expression and binding of [C]SMW139 in other neurological diseases involving microglial activation is warranted.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5920098 | PMC |
| http://dx.doi.org/10.1038/s41598-018-24814-0 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mechanistic insights into the selective targeting of P2X3 receptor by camlipixant antagonist.
J Biol Chem
December 2024
Department of Biological Sciences, Purdue University, West Lafayette, IN-47907, USA; Weldon School of Biomedical Engineering, Purdue University, West Lafayette, IN-47907, USA. Electronic address:
ATP-activated P2X3 receptors play a pivotal role in chronic cough, affecting more than 10% of the population. Despite the challenges posed by the highly conserved structure of P2X receptors, efforts to develop selective drugs targeting P2X3 have led to the development of camlipixant, a potent, selective P2X3 antagonist. However, the mechanisms of receptor desensitization, ion permeation, and structural basis of camlipixant binding to P2X3 remain unclear.
View Article and Find Full Text PDFP2X -receptor binding in new-onset and secondary progressive MS - a [C]SMW139 PET study.
EJNMMI Res
December 2024
Turku PET Centre, Turku, Finland.
Background: PET imaging of activated microglia has improved our understanding of the pathology behind disability progression in MS, and pro-inflammatory microglia at 'smoldering' lesion rims have been implicated as drivers of disability progression. The P2X R is upregulated in the cellular membranes of activated microglia. A single-tissue dual-input model was applied to quantify P2X R binding in the normal appearing white matter, perilesional areas and thalamus among progressive MS patients, healthy controls and newly diagnosed relapsing MS patients.
View Article and Find Full Text PDFTumor-Associated Microglia Secrete Extracellular ATP to Support Glioblastoma Progression.
Cancer Res
December 2024
Department of Neurosurgery, Stanford University School of Medicine, Stanford, California.
Article Synopsis
- Glioblastoma (GBM) is a difficult-to-treat brain cancer characterized by aggressive behavior and high rates of recurrence, with tumor-associated microglia and macrophages (TAM) playing a significant role in its immune microenvironment.
- Researchers found that TAMs in the tumor core show higher ATP synthase expression and activity, leading to increased energy production and metabolic changes in the presence of GBM cells, which in turn stimulate tumor growth.
- Targeting the signaling pathway involving elevated extracellular ATP (eATP) and the P2X purinoceptor 7 (P2X7R) has the potential to decrease tumor growth and improve survival rates in models of GBM, highlighting a new therapeutic strategy.
Purinergic P2Y and P2Y receptors control enteric nervous system activity through neuro-glia-macrophage crosstalk.
Purinergic Signal
November 2024
Department of Physiology, Michigan State University, 567 Wilson Road, East Lansing, MI, 48824, USA.
Purines are important mediators of intercellular communication in the enteric nervous system (ENS) that participate in physiological gut functions and disease. Purinergic transmission is prominent in mechanisms of crosstalk between enteric neurons and glia where enteric glia exhibit high responsiveness to adenosine diphosphate (ADP) through P2Y receptors and neurons to adenosine triphosphate (ATP) through P2X receptors. Despite functional data suggesting that enteric glia are the primary site of P2Y expression in the ENS, gene sequencing suggests that P2Y expression is more enriched in neurons than glia.
View Article and Find Full Text PDFOverexpression of the inwardly rectifying potassium channel Kir4.1 or Kir4.1 Tyr9 Asp in Müller cells exerts neuroprotective effects in an experimental glaucoma model.
Neural Regen Res
November 2024
State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institute of Brain Science, Fudan University, Shanghai, China.
Downregulation of the inwardly rectifying potassium channel Kir4.1 is a key step for inducing retinal Müller cell activation and interaction with other glial cells, which is involved in retinal ganglion cell apoptosis in glaucoma. Modulation of Kir4.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!